Evaluation of Diabetes Drug Safety

A hearing was held on the role of the Food and Drug Administration in evaluating the safety of Avandia, a drug used in the treatment of Type 2 diabetes. FDA… read more

A hearing was held on the role of the Food and Drug Administration in evaluating the safety of Avandia, a drug used in the treatment of Type 2 diabetes. FDA officials testified about post-marketing surveillance of new drugs and “meta-analysis.” Avandia was approved by the FDA in 1999. Dr. Nissen testified about his study linking Avandia use with a 43 percent increased risk of heart attack. Dr. Buse testified about increased cholesterol in Avandia-using patients. Witnesses emphasized the need for earlier studies and more sensitive protocols. Dr. Slaoui testified about GlaxoSmithKline’s research and actions.

Dr. Buse is also the president-elect for medicine and science of the American Diabetes Association. close

Report Video Issue

People in this video

More People

Hosting Organization

More information about

Evaluation of Diabetes Drug Safety

266 Views
Program ID:
198496-1
Category:
House Committee
Format:
House Committee
Location:
Washington, District of Columbia, United States
First Aired:
Jun 07, 2007 | 12:43am EDT | C-SPAN 2
Last Aired:
Jun 08, 2007 | 9:35pm EDT | C-SPAN 2

Airing Details

  • Jun 07, 2007 | 12:43am EDT | C-SPAN 2
  • Jun 08, 2007 | 2:56pm EDT | C-SPAN 2
  • Jun 08, 2007 | 9:35pm EDT | C-SPAN 2
Purchase a Download

Evaluation of Diabetes Drug Safety

  • MP4 video - Standard
    Price:
    $9.99 or Free with MyC‑SPAN
  • MP3 audio - Standard
    Price:
    $0.99

User Created Clips from This Video